HLA-B46:01:01:01 and HLA-DRB109:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplas...
HLA-B46:01:01:01 and HLA-DRB109:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Treatment of anemia in patients with chronic kidney disease (CKD) with recombinant human erythropoietin (rHuEPO) can be disrupted by a severe complication, anti-rHuEPO-induced pure red cell aplasia (PRCA). Specific HLA genotypes may have played a role in the high incidence of PRCA in Thai patients (1.7/1,000 patient years vs. 0.03/10,000 patient ye...
Alternative Titles
Full title
HLA-B46:01:01:01 and HLA-DRB109:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_505759a81ea849a880c24bcb82546ffe
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_505759a81ea849a880c24bcb82546ffe
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-023-50211-3
